WuXi Biologics (Cayman) Inc. (WXXWY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    WuXi Biologics (Cayman) I...

    OTC: WXXWY · Real-Time Price · USD
    7.85
    -0.22 (-2.73%)
    At close: Aug 28, 2025, 3:58 PM
    8.01
    2.04%
    After-hours: Aug 28, 2025, 02:31 PM EDT

    WuXi Biologics (Cayman) Balance Sheet Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Cash & Equivalents
    		 8.28B 9.15B 9.67B 7.36B 6.4B 8.14B 9B 11.28B
    Short-Term Investments
    		 2.43B 375.15M 1.57B 248.45M 304.47M 335.57M 1.15B 1.92B
    Long-Term Investments
    		 -30.78M 2.81B 2.93B 2.76B 2.71B 2.43B 2.2B 1.61B
    Other Long-Term Assets
    		 2.58B 700.37M 226.19M -263.6M -222.57M -244.64M -220.79M -174.71M
    Receivables
    		 5.79B 6.22B 6.18B 5.39B 5.16B 5.56B 3.27B 2.91B
    Inventory
    		 1.52B 1.96B 1.77B 1.97B 2.28B 2.14B 1.69B 1.71B
    Other Current Assets
    		 5.47B 2.01B 2B 1.82B 2.32B 3.09B 3.44B 3.42B
    Total Current Assets
    		 23.57B 19.82B 21.2B 17.88B 18.47B 20.66B 19.53B 21.98B
    Property-Plant & Equipment
    		 28.44B 30.78B 29.94B 28.99B 25.92B 21.85B 19.76B 17.74B
    Goodwill & Intangibles
    		 1.97B 2B 2.04B 2.07B 2.08B 2.09B 2.13B 1.92B
    Total Long-Term Assets
    		 33.4B 36.29B 35.38B 33.83B 30.7B 26.37B 24.09B 21.27B
    Total Assets
    		 56.98B 56.11B 56.58B 52.14B 49.56B 47.47B 44.03B 43.58B
    Account Payables
    		 747.15M 874.53M 833.27M 573.2M 794.39M 995.33M 617.78M 534.61M
    Deferred Revenue
    		 n/a n/a -154.98M -1.28B -1.47B -2.47B -2.23B -1.29B
    Short-Term Debt
    		 2.44B 892.6M 576.33M 1.16B 1.32B 2.35B 2.12B 1.16B
    Other Current Liabilities
    		 2.58B 3.93B 5.27B 5.37B 6.06B 5.07B 4.56B 3.17B
    Total Current Liabilities
    		 8.62B 6.81B 7.64B 8.14B 9.32B 9B 8.26B 5.44B
    Long-Term Debt
    		 200.9M 1.26B 1.57B 1.66B 1.46B 531.9M 640.51M 2.07B
    Other Long-Term Liabilities
    		 n/a 1.17B n/a -6.59B -5.14B -4.93B -4.86B -1.23B
    Total Long-Term Liabilities
    		 2.88B 4.66B 4.92B 1.66B 1.46B 531.9M 640.51M 2.07B
    Total Liabilities
    		 11.5B 11.46B 12.56B 13.1B 13.35B 11.99B 11.33B 10B
    Total Debt
    		 4.94B 4.57B 4.56B 5.14B 4.42B 4.4B 4.3B 4.6B
    Common Stock
    		 226K 228K 235K 234K 233K 235K 235K 234K
    Retained Earnings
    		 16.36B n/a 13.49B 12.78B 11.58B 9.69B 7.16B 5.61B
    Comprehensive Income
    		 n/a n/a 1.78B 37.74B 1.37B 712.48M 593.13M 633.19M
    Shareholders Equity
    		 41.82B 40.66B 40.33B 37.74B 35.05B 34.46B 32.28B 33.22B
    Total Investments
    		 2.4B 3.15B 2.93B 3.01B 3.01B 2.77B 3.35B 3.53B

    Add to Watchlist